As of Mar 15, 2019 ESCALON MED CORP (OTCMKTS:ESMC) Sellers Decreased Their Shorts By 75%

ESCALON MED CORP (OTCMKTS:ESMC) reported a decrease of 75% in shorted shares. In March was issued ESMC’s total 100 shorted shares by FINRA. The down change of 75% from 400 shares was reported. ESCALON MED CORP (OTCMKTS:ESMC) has 2,000 shares average volume. It’ll cost 0 days for ESMC to restore its former position.

ESMC is hitting $0.103 during the last trading session, after decreased 2.37%.Escalon Medical Corp. has 30,100 shares volume, 280.63% up from normal. ESMC is and has moved 0.00% since March 15, 2018. ESMC underperformed by 4.37% the S&P 500.

Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and Europe.The company has $763,779 market cap. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea.Last it reported negative earnings. The firm also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; and Ispan intraocular gases, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery, as well as a patented disposable universal gas kit that delivers the gas from the canister to the patient.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.